Darnytsia Pharmaceutical Company

What Darnytsia Pharmaceutical Company does

Darnytsia Pharmaceutical Company (PrJSC Pharmaceutical Firm Darnytsia) is a privately held Ukrainian pharmaceutical manufacturer founded in 1929 and headquartered in Kyiv. The company operates GMP-certified production facilities and manufactures over 180 medicinal products, with stated focus areas in cardiology, neurology, and pain management. Its portfolio is anchored by branded franchises including the Darfen analgesic line (multiple formulations from tablets and gel to pediatric suspensions and soft-gel capsules), the Eridez antihistamine line (orodispersible, film-coated tablets, and syrup), as well as legacy brands such as Citramon-Darnitsa, Paracetamol-Darnitsa, Darsil, and Medikhronal-Darnitsa. The company's product page highlights several proprietary formulation technologies, including a combination ibuprofen-paracetamol release profile providing rapid onset (~18 minutes) and prolonged analgesic effect (~9 hours), soft-gel capsules with ibuprofen dissolved in hydrophilic solvent for faster plasma absorption, and desloratadine orodispersible tablets engineered for use without water.

Darnytsia describes itself as the leader of the Ukrainian pharmaceutical market by sales volume in natural terms and reports export to more than 20 countries. The company employs 397 staff and operates a direct-to-consumer go-to-market model combining pharmacy chain distribution (Apteka 911, ANC, Apteka Dobrogo Dnia, Med-Service, Podorozhnyk, Бажаємо здоров'я), online pharmacy aggregators (Tabletki.ua, Apteka.net.ua), Ukraine's largest e-commerce marketplace (Rozetka), participation in the state 'Accessible Medicines' (Доступні ліки) reimbursement program, a 20% military discount through the Army+ platform, and a company-owned branded pharmacy in Kyiv. Its marketing approach includes an Educational Hub for physicians and patients, and a 'Heart Beats' podcast produced in partnership with the Institute of Heart. No revenue, funding, M&A, or AI capability data is disclosed in the source material.

Name

Darnytsia Pharmaceutical Company

Legal name

ПрАТ «Фармацевтична фірма «Дарниця»

Website

https://darnytsia.ua

Company type

Private

Founded year

1929

Operating status

Operating

Headcount range

251–500 employees

Short description

Darnytsia Pharmaceutical Company is a privately held Ukrainian pharmaceutical manufacturer founded in 1929, producing over 180 GMP-certified medicines focused on cardiology, neurology, and pain management, distributed through pharmacy chains, online platforms, and a state reimbursement program domestically and across 20+ export markets.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254), Pharmacies and Drug Retailers (456110)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)

Keywords

• Generic pharmaceuticals manufacturing
• Analgesic medications
• Cardiology drugs
• Antihistamine medications
• Over-the-counter medicines

Headquarters

HQ city

Kyiv

HQ country

Ukraine

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of over 180 pharmaceutical products including analgesics, antihistamines, and cardiovascular medications through pharmacy chains, retail outlets, and direct-to-consumer channels in Ukraine and export markets.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels5 records

Core offering

Darnytsia manufactures and distributes over 180 branded and generic pharmaceutical products at GMP-certified facilities in Kyiv, with primary therapeutic focus on cardiology, neurology, and pain management. The product range spans analgesics, antipyretics, antihistamines, hepatoprotectives, and other categories, sold through pharmacy chains, online pharmacies, e-commerce platforms, and government/military programs in Ukraine and export markets.

Product overview

Darnytsia Pharmaceutical Company is a Ukrainian pharmaceutical manufacturer producing over 180 medicinal products organized primarily around three therapeutic focus areas: cardiology, neurology, and pain management. The core product portfolio includes multiple analgesic lines (Paracetamol-Darnitsa, Ibuprofen-Darnitsa, Citramon-Darnitsa, and the Darfen family including Darfen Long, Darfen Gel, Darfen Kids/Forte, Darfen Express, Darfen Ultracap 200/400, and standard Darfen tablets), antihistamine products (Eridez in orodispersible tablet, film-coated tablet, and syrup formulations), hepatoprotective agents (Darsil), and anti-alcohol intoxication treatment (Medikhronal-Darnitsa). The Darfen franchise represents the company's primary pain management sub-brand with multiple delivery formats, while Eridez covers allergy treatment across age groups. All products are manufactured according to GMP (Good Manufacturing Practice) standards.

Differentiator

Problem solved

Functional benefit

Brands

• Дарфен (Darfen): Pain management product line including tablets, capsules, gel, and children's formulations (Darfen Long, Darfen Kids, Darfen Kids Forte, Darfen Express, Darfen Ultracap)
• Ерідез (Eridez)
• Цитрамон-Дарниця (Citramon-Darnitsa)
• Парацетамол-Дарниця (Paracetamol-Darnitsa)
• Медихронал-Дарниця (Medikhronal-Darnitsa)
• Дарсіл (Darsil)

Products and services

• Ibuprofen-Darnitsa NSAID analgesic product based on ibuprofen for pain and inflammation management, distributed as a Darnytsia branded medicine.
• Mefenaminka Antipyretic and anti-inflammatory medication in the Darnytsia portfolio for fever and inflammation relief.
• Paracetamol-Darnitsa Analgesic and antipyretic containing paracetamol for mild to moderate pain and fever relief, available in 200mg and 500mg tablets.
• Citramon-Darnitsa Combination analgesic containing acetylsalicylic acid, paracetamol, and caffeine for mild to moderate pain and fever.
• Eridez (orodispersible tablets) Antihistamine with desloratadine in banana-flavored orodispersible tablet form that dissolves in the mouth without water, for allergic rhinitis and urticaria symptoms.
• Eridez (syrup) Antihistamine syrup with desloratadine for children from 6 months, treating allergic rhinitis and urticaria.
• Eridez (film-coated tablets) Film-coated antihistamine tablets with desloratadine for systemic allergy treatment of allergic rhinitis and urticaria.
• Darfen Long (tablets) Combination analgesic tablets with 200mg ibuprofen and 500mg paracetamol for mild to moderate pain including migraine, headache, back pain, menstrual pain, toothache, and fever.
• Darfen Ultracap 400 (capsules) Soft gel capsules containing 400mg ibuprofen dissolved in hydrophilic solvent for enhanced absorption, treating mild to moderate pain and fever.
• Darfen Gel Topical analgesic gel formulation for localized pain relief.
• Darfen Kids (suspension) Pediatric ibuprofen oral suspension for children's pain and fever relief.
• Darfen Kids Forte (suspension) Higher-concentration pediatric ibuprofen oral suspension for enhanced dosing in children.
• Darfen Express (stick suspension) Convenient stick-pack ibuprofen suspension for on-the-go pain and fever relief.
• Darfen (standard tablets) Standard ibuprofen tablets for pain and inflammation management.
• Darfen Ultracap 200 (capsules) Soft gel capsules with 200mg ibuprofen for mild pain relief.
• Darsil Hepatoprotective medication that accelerates liver cell regeneration.
• Medikhronal-Darnitsa Medication that reduces symptoms of alcohol intoxication and accelerates regeneration of liver cells.

Quantifiable outcome

• Products available in 20+ countries worldwide
• +2 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Institute of HeartcoreStrategic or Co-development PartnerPartnership for the 'Heart Beats' (Серце б'ється) podcast series, providing educational content about cardiovascular health. This collaboration creates multimedia content for patients on heart-related topics.
• Accessible Medicines Program (Доступні ліки)coreGTM or Marketing PartnerPartnership with Ukrainian government healthcare program providing affordable access to essential medicines. Darnytsia products are included in the list of accessible medicines available to patients.
• Army+ PlatformminorGTM or Marketing PartnerPartnership providing 20% discounts on Darnytsia products for military personnel and their families through the Army+ application platform.

Scale indicators5 records

Recent moves6 records

Expansion highlights15 records

Broad incumbents

• KRKA: KRKA is a Slovenian multinational generic pharmaceutical manufacturer with a strong presence in CEE, CIS, and Eastern Europe. It is a relevant incumbent peer because of its similar generic-pharma model, overlapping therapeutic areas, and active footprint in the Ukrainian market.
• Teva Pharmaceutical Industries: Teva is the world's largest generic medicines producer with a broad OTC and specialty generics portfolio. Although global in scale, it competes with Darnytsia in generic analgesics, antihistamines, and neurology products across overlapping markets.
• Gedeon Richter: Gedeon Richter is a Hungarian multinational pharmaceutical company with branded generics and specialty drugs in cardiology, neurology, and women's health. It is a comparable peer given its CEE origin, similar therapeutic focus, and established presence in CIS markets.
• Stada Arzneimittel: Stada is a European generics and consumer healthcare company with branded OTC and specialty generics across cardiology, neurology, and pain management. It competes with Darnytsia in CEE markets and is comparable in business model and product mix.
• Berlin-Chemie (Menarini Group): Berlin-Chemie is the German affiliate of the Menarini Group, producing branded cardiovascular, pain, and OTC products in Eastern Europe and CIS. It is comparable as an incumbent operating in the same therapeutic categories and geographies as Darnytsia.

Direct peers

• Arterium: Arterium is a major Ukrainian pharmaceutical group (combining Kyivmedpreparat and Halychpharm) producing generic and branded pharmaceuticals across cardiology, neurology, and pain management. It directly overlaps Darnytsia's therapeutic focus areas and competes in the same pharmacy and government channels.
• Indar (Indar-CIS): Indar is a Ukrainian pharmaceutical manufacturer producing generic and specialty medicines, including injectables. It is a direct domestic competitor competing for the same pharmacy distribution, generic molecule overlap, and government procurement opportunities.
• Farmak: Farmak is a leading Ukrainian pharmaceutical manufacturer headquartered in Kyiv, producing a broad portfolio of finished dosage forms across multiple therapeutic areas. It is the most direct domestic competitor to Darnytsia, competing for the same pharmacy shelf space and government reimbursement listings.

Regional players

• Zdorovye (LLC Pharmaceutical Company Zdorovye): Zdorovye is a Ukrainian pharmaceutical manufacturer producing generic and OTC medicines across cardiovascular and pain management categories. It is a regional peer operating in the same domestic market with similar product categories and distribution channels.
• Polpharma: Polpharma is the largest Polish pharmaceutical manufacturer, producing generic and OTC medicines across cardiovascular, pain, and neurology categories. It is comparable as a regional generic/OTC manufacturer operating in overlapping Central and Eastern European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/playlist?list=PLKO6IA9O3NjR5HQUwtiQzgvFMcqkQs-Q3&si=dtV8PFSRV54ys5JG
• LinkedInlinkedin.com/company/darnytsia

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Darnytsia Pharmaceutical Company